Glucocorticoid-Induced Diabetes Mellitus: An Important but Overlooked Problem
Sunghwan Suh (Suh S), Mi Kyoung Park (Park MK)
Endocrinol Metab. 2017;32(2):180-189.   Published online 2017 May 29     DOI: https://doi.org/10.3803/EnM.2017.32.2.180
Citations to this article as recorded by Crossref logo
Prednisolone-induced diabetes mellitus in the cat: a historical cohort
Sivert Nerhagen, Hanne L Moberg, Gudrun S Boge, Barbara Glanemann
Journal of Feline Medicine and Surgery.2021; 23(2): 175.     CrossRef
Mechanisms and Clinical Applications of Glucocorticoid Steroids in Muscular Dystrophy
Mattia Quattrocelli, Aaron S. Zelikovich, Isabella M. Salamone, Julie A. Fischer, Elizabeth M. McNally
Journal of Neuromuscular Diseases.2021; 8(1): 39.     CrossRef
A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes
Thomas Forst, Pratik Choudhary, Doron Schneider, Bruno Linetzky, Paolo Pozzilli
Diabetes/Metabolism Research and Reviews.2021;[Epub]     CrossRef
Incidence and control of steroid-induced hyperglycaemia in hospitalised patients at a tertiary care centre for lung diseases
Matej Dobravc Verbič, Jasna Gruban, Mojca Kerec Kos
Pharmacological Reports.2021; 73(3): 796.     CrossRef
Epigenetics in blood–brain barrier disruption
Stephanie A. Ihezie, Iny Elizebeth Mathew, Devin W. McBride, Ari Dienel, Spiros L. Blackburn, Peeyush Kumar Thankamani Pandit
Fluids and Barriers of the CNS.2021;[Epub]     CrossRef
Risk factors for corticosteroid-induced hyperglycemia requiring insulin therapy in hospitalized patients without diabetes
Catherine Li, Patricia Krause, Gretchen Stern
Endocrine.2021; 73(2): 476.     CrossRef
Population pharmacodynamic modeling of intramuscular and oral dexamethasone and betamethasone effects on six biomarkers with circadian complexities in Indian women
Wojciech Krzyzanski, Mark A. Milad, Alan H. Jobe, Thomas Peppard, Robert R. Bies, William J. Jusko
Journal of Pharmacokinetics and Pharmacodynamics.2021; 48(3): 411.     CrossRef
Hormonal activity in commonly used Black hair care products: evaluating hormone disruption as a plausible contribution to health disparities
Tamarra James-Todd, Lisa Connolly, Emma V. Preston, Marlee R. Quinn, Monika Plotan, Yuling Xie, Bharathi Gandi, Shruthi Mahalingaiah
Journal of Exposure Science & Environmental Epidemiology.2021; 31(3): 476.     CrossRef
New‐onset diabetes in “long COVID ”
Thirunavukkarasu Sathish, Mary Chandrika Anton, Tharsan Sivakumar
Journal of Diabetes.2021; 13(8): 693.     CrossRef
Glucocorticoid-Induced Exacerbation of Mycobacterial Infection Is Associated With a Reduced Phagocytic Capacity of Macrophages
Yufei Xie, Jiajun Xie, Annemarie H. Meijer, Marcel J. M. Schaaf
Frontiers in Immunology.2021;[Epub]     CrossRef
Glucocorticoid signaling in pancreatic islets modulates gene regulatory programs and genetic risk of type 2 diabetes
Anthony Aylward, Mei-Lin Okino, Paola Benaglio, Joshua Chiou, Elisha Beebe, Jose Andres Padilla, Sharlene Diep, Kyle J. Gaulton, Michael L. Stitzel
PLOS Genetics.2021; 17(5): e1009531.     CrossRef
A Practical Guide for the Management of Steroid Induced Hyperglycaemia in the Hospital
Felix Aberer, Daniel A. Hochfellner, Harald Sourij, Julia K. Mader
Journal of Clinical Medicine.2021; 10(10): 2154.     CrossRef
Combination of Bawang Dayak Extract and Acarbose against Male White Rat Glucose Levels
Aditya Maulana Perdana Putra, Ratih Pratiwi Sari, Siska Musiam
Borneo Journal of Pharmacy.2021; 4(2): 84.     CrossRef
Role of Gliclazide in safely navigating type 2 diabetes mellitus patients towards euglycemia: Expert opinion from India
Subhash Wangnoo, M. Shunmugavelu, Sagili Vijaya Bhaskar Reddy, Vijay Negalur, Shreerang Godbole, Vinay K Dhandhania, Nareen Krishna, Kumar Gaurav
Endocrine and Metabolic Science.2021; 4: 100102.     CrossRef
Genome-Wide Differential Methylation Profiles from Two Terpene-Rich Medicinal Plant Extracts Administered in Osteoarthritis Rats
Younhee Shin, Sathiyamoorthy Subramaniyam, Jin-Mi Chun, Ji-Hyeon Jeon, Ji-Man Hong, Hojin Jung, Boseok Seong, Chul Kim
Plants.2021; 10(6): 1132.     CrossRef
Chronic glucocorticoid treatment induces hepatic lipid accumulation and hyperinsulinaemia in part through actions on AgRP neurons
Erika Harno, Charlotte Sefton, Jonathan R. Wray, Tiffany-Jayne Allen, Alison Davies, Anthony P. Coll, Anne White
Scientific Reports.2021;[Epub]     CrossRef
Endocrine Disorders in Autoimmune Rheumatological Diseases: A Focus on Thyroid Autoimmune Diseases and on the Effects of Chronic Glucocorticoid Treatment
Filippo Egalini, Mirko Parasiliti Caprino, Giulia Gaggero, Vincenzo Cappiello, Jacopo Giannelli, Ruth Rossetto Giaccherino, Loredana Pagano, Roberta Giordano
Endocrines.2021; 2(3): 171.     CrossRef
Current cancer therapies and their influence on glucose control
Carly Yim, Kerry Mansell, Nassrein Hussein, Terra Arnason
World Journal of Diabetes.2021; 12(7): 1010.     CrossRef
Immune‐checkpoint inhibitor‐associated diabetes compared to other diabetes types ‐ A prospective, matched control study
Sascha R. Tittel, Katharina Laubner, Sebastian M. Schmid, Stefan Kress, Sigrun Merger, Wolfram Karges, Frank J. Wosch, Marcus Altmeier, Marianne Pavel, Reinhard W. Holl
Journal of Diabetes.2021; 13(12): 1007.     CrossRef
Connecting the Dots: Interplay of Pathogenic Mechanisms between COVID-19 Disease and Mucormycosis
Hariprasath Prakash, Anna Skiada, Raees Ahmad Paul, Arunaloke Chakrabarti, Shivaprakash Mandya Rudramurthy
Journal of Fungi.2021; 7(8): 616.     CrossRef
Antioxidant effects of L-citrulline supplementation in high-fat diet- and dexamethasone-induced Type-2 diabetes mellitus in wistar rats (Rattus norvegicus)
Evelyn Hassan-Danboyi, Abdulazeez Jimoh, Abdulwahab Alhassan, Timothy Danboyi, KabirAhmed Mohammed, AugustineBanlibo Dubo, Jamilu Haruna, BulusBilly Yakubu
Nigerian Journal of Experimental and Clinical Biosciences.2021; 9(2): 95.     CrossRef
ASSESSMENT OF THE POSSIBLE CAUSES OF DIABETES MELLITUS DEVELOPED IN PATIENTS POST COVID-19 TREATMENT IN A TERTIARY CARE HOSPITAL
KHUJITH RAJUENI, RUTUJA AMBEKAR, HITENDRAPAL SOLANKI, ABDULRAHAMAN ABUBAKAR MOMIN, SUNITA PAWAR
International Journal of Pharmacy and Pharmaceutical Sciences.2021; : 11.     CrossRef
Potent Anti-Inflammatory, Arylpyrazole-Based Glucocorticoid Receptor Agonists That Do Not Impair Insulin Secretion
Brandon J. Kennedy, Ashley M. Lato, Alexander R. Fisch, Susan J. Burke, Justin K. Kirkland, Carson W. Prevatte, Lee E. Dunlap, Russell T. Smith, Konstantinos D. Vogiatzis, J. Jason Collier, Shawn R. Campagna
ACS Medicinal Chemistry Letters.2021; 12(10): 1568.     CrossRef
Corticosteroids for COVID-19: worth it or not?
Fariya Akter, Yusha Araf, Mohammad Jakir Hosen
Molecular Biology Reports.2021;[Epub]     CrossRef
Evidence-Based Management of Steroid-Induced Hyperglycemia in the Inpatient Setting
Lauren Longaker, Jennifer N. Clements
ADCES in Practice.2021; : 2633559X2110569.     CrossRef
Risk of Future Type 2 Diabetes Mellitus in Patients Developing Steroid-Induced Hyperglycemia During Hospitalization for Chronic Obstructive Pulmonary Disease Exacerbation
Jagriti Upadhyay, Nitin Trivedi, Amos Lal
Lung.2020; 198(3): 525.     CrossRef
Acetylation of Hsp90 reverses dexamethasone-mediated inhibition of insulin secretion
Kecheng Zhu, Yumei Zhang, Juan Zhang, Feiye Zhou, Linlin Zhang, Shushu Wang, Qin Zhu, Qianqian Liu, Xiao Wang, Libin Zhou
Toxicology Letters.2020; 320: 19.     CrossRef
Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary disease
Mohamad Isam Saeed, Josefin Eklöf, Imane Achir, Pradeesh Sivapalan, Howraman Meteran, Anders Løkke, Tor Biering‐Sørensen, Filip Krag Knop, Jens‐Ulrik Stæhr Jensen
Diabetes, Obesity and Metabolism.2020; 22(8): 1348.     CrossRef

Patterns of Glucose Fluctuation are Challenging in Patients Treated for Non-Hodgkin’s Lymphoma

Andreja Marić, Tanja Miličević, Jelena Vučak Lončar, Davor Galušić, Maja Radman
International Journal of General Medicine.2020; Volume 13: 131.     CrossRef
Metformin's effectiveness in preventing prednisone-induced hyperglycemia in hematological cancers
Lucy A Ochola, David G Nyamu, Eric M Guantai, Irene W Weru
Journal of Oncology Pharmacy Practice.2020; 26(4): 823.     CrossRef
Study rationale and design of the EANITIATE study (EmpAgliflozin compared to NPH Insulin for sTeroId diAbeTEs) - a randomized, controlled, multicenter trial of safety and efficacy of treatment with empagliflozin compared with NPH-insulin in patients with
Carina Kirstine Klarskov, Helga Holm Schultz, Frederik Persson, Tomas Møller Christensen, Thomas Peter Almdal, Ole Snorgaard, Katrine Bagge Hansen, Ulrik Pedersen-Bjergaard, Peter Lommer Kristensen
BMC Endocrine Disorders.2020;[Epub]     CrossRef
Implementation of a Weight-Based Protocol for the Management of Steroid-Induced Hyperglycemia
Alyson K. Myers, Mahmuda Khan, Sebastian Choi, Patricia Garnica, Guillaume Stoffels, Amanda Lin
American Journal of Therapeutics.2020; 27(4): e392.     CrossRef
The difference between steroid diabetes mellitus and type 2 diabetes mellitus: a whole-body 18F-FDG PET/CT study
Qingqing Zhao, Jinxin Zhou, Yu Pan, Huijun Ju, Liying Zhu, Yang Liu, Yifan Zhang
Acta Diabetologica.2020; 57(11): 1383.     CrossRef
Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis
Jianhua Wu, Sarah L Mackie, Mar Pujades-Rodriguez
BMJ Open Diabetes Research & Care.2020; 8(1): e001220.     CrossRef
Diabète et corticoïdes : nouveautés et aspects pratiques
M. Bastin, F. Andreelli
La Revue de Médecine Interne.2020; 41(9): 607.     CrossRef
Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes
Janine Alessi, Giovana B. de Oliveira, Beatriz D. Schaan, Gabriela H. Telo
Diabetology & Metabolic Syndrome.2020;[Epub]     CrossRef
Glycemic Response to Oral Dexamethasone Predicts Incident Prediabetes in Normoglycemic Subjects With Parental Diabetes
Ebenezer Nyenwe, Deirdre James, Jim Wan, Sam Dagogo-Jack
Journal of the Endocrine Society.2020;[Epub]     CrossRef
Outcomes of Hospitalized Patients with Glucocorticoid-Induced Hyperglycemia—A Retrospective Analysis
Neele Delfs, Tristan Struja, Sandra Gafner, Thaddaeus Muri, Ciril Baechli, Philipp Schuetz, Beat Mueller, Claudine Angela Blum
Journal of Clinical Medicine.2020; 9(12): 4079.     CrossRef
Incidence of Hyperglycemia/Secondary Diabetes in Women who have Undergone Curative Chemotherapy for Breast Cancer: First Study from India
Suresh Rao, Krishna Prasad, Soniya Abraham, Thomas George, Supreeth Kakkaje Chandran, Manjeshwar Shrinath Baliga
South Asian Journal of Cancer.2020; 09(03): 130.     CrossRef
What is the optimal time for measuring glucose concentration to detect steroid-induced hyperglycemia in patients with rheumatic diseases?
Güven Barış Cansu, Döndü Üsküdar Cansu, Bengür Taşkıran, Şule Yaşar Bilge, Muzaffer Bilgin, Cengiz Korkmaz
Clinical Biochemistry.2019; 67: 33.     CrossRef
Risedronate Attenuates Podocyte Injury in Phosphate Transporter-Overexpressing Rats
Yohei Asada, Takeshi Takayanagi, Tsukasa Kawakami, Eisuke Tomatsu, Atsushi Masuda, Yasumasa Yoshino, Sahoko Sekiguchi-Ueda, Megumi Shibata, Tomihiko Ide, Hajime Niimi, Eishin Yaoita, Yusuke Seino, Yoshihisa Sugimura, Atsushi Suzuki
International Journal of Endocrinology.2019; 2019: 1.     CrossRef
Novel aspects of PCSK9 and lipoprotein receptors in renal disease-related dyslipidemia
Pragyi Shrestha, Bart van de Sluis, Robin P.F. Dullaart, Jacob van den Born
Cellular Signalling.2019; 55: 53.     CrossRef
Understanding the burden of refractory myasthenia gravis
Christiane Schneider-Gold, Tim Hagenacker, Nico Melzer, Tobias Ruck
Therapeutic Advances in Neurological Disorders.2019; 12: 175628641983224.     CrossRef
Drug-induced diabetes type 2: In silico study involving class B GPCRs
Dorota Latek, Ewelina Rutkowska, Szymon Niewieczerzal, Judyta Cielecka-Piontek, Arun Shukla
PLOS ONE.2019; 14(1): e0208892.     CrossRef
Periodically repeated rituximab administrations in children with refractory nephrotic syndrome: 2-year multicenter observational study
Toshiyuki Takahashi, Takayuki Okamoto, Yasuyuki Sato, Takeshi Yamazaki, Asako Hayashi, Hayato Aoyagi, Michihiko Ueno, Norio Kobayashi, Kimiaki Uetake, Masanori Nakanishi, Tadashi Ariga
Pediatric Nephrology.2019; 34(1): 87.     CrossRef
Management of hyperglycaemia in persons with non-insulin-dependent type 2 diabetes mellitus who are started on systemic glucocorticoid therapy: a systematic review
Milos Tatalovic, Roger Lehmann, Marcus Cheetham, Albina Nowak, Edouard Battegay, Silvana K Rampini
BMJ Open.2019; 9(5): e028914.     CrossRef
The effect of diabetes mellitus on in-hospital hyperglycemia, length of stay and survival in patients with brain tumor receiving dexamethasone: A descriptive and comparative analysis
Panteleimon Pantelidis, Parmenion P. Tsitsopoulos, Eleni Pappa, Elpida Theologou, Nikolaos Karanikolas, Christos Drosos, Christos Tsonidis
Clinical Neurology and Neurosurgery.2019; 184: 105450.     CrossRef
Impact of glucocorticoid treatment before pregnancy on glucose homeostasis of offspring exposed to glucocorticoid in adult life
Flávia Natividade da Silva, Henver Simionato Brunetta, Maciel Alencar Bruxel, Felipe Azevedo Gomes, Alex Rafacho
Life Sciences.2019; 237: 116913.     CrossRef
One week of continuous corticosterone exposure impairs hepatic metabolic flexibility, promotes islet β-cell proliferation, and reduces physical activity in male C57BL/6 J mice
Susan J. Burke, Heidi M. Batdorf, Tai-Yu Huang, Joseph W. Jackson, Katarina A. Jones, Thomas M. Martin, Kristen E. Rohli, Michael D. Karlstad, Tim E. Sparer, David H. Burk, Shawn R. Campagna, Robert C. Noland, Paul L. Soto, J. Jason Collier
The Journal of Steroid Biochemistry and Molecular Biology.2019; 195: 105468.     CrossRef
Effect of preadmission glucocorticoid therapy on 30-day mortality in critically ill patients: a retrospective study of a mixed ICU population in a tertiary hospital
Tak Kyu Oh, In-Ae Song, Jae Ho Lee, Cheong Lim, Young-Tae Jeon, Hee-Joon Bae, You Hwan Jo
Annals of Intensive Care.2019;[Epub]     CrossRef
Hospitalization as an Opportunity to Optimize Glycemic Control in Oncology Patients
Amy Hiestand, James Flory, Ritika Chitkara
Current Diabetes Reports.2019;[Epub]     CrossRef
Corticothérapie prolongée chez une personne âgée et diabète
J.L. Schlienger
Médecine des Maladies Métaboliques.2018; 12(7): 599.     CrossRef
Activation of nuclear receptor PXR impairs glucose tolerance and dysregulates GLUT2 expression and subcellular localization in liver
Fatemeh Hassani-Nezhad-Gashti, Jaana Rysä, Outi Kummu, Juha Näpänkangas, Marcin Buler, Mikko Karpale, Janne Hukkanen, Jukka Hakkola
Biochemical Pharmacology.2018; 148: 253.     CrossRef
Diabetes Mellitus Secondary to Cushing’s Disease
Mattia Barbot, Filippo Ceccato, Carla Scaroni
Frontiers in Endocrinology.2018;[Epub]     CrossRef
MANAGEMENT OF ENDOCRINE DISEASE: Critical review of the evidence underlying management of glucocorticoid-induced hyperglycaemia
Anjana Radhakutty, Morton G Burt
European Journal of Endocrinology.2018; 179(4): R207.     CrossRef
Use of parenteral glucocorticoids and the risk of new onset type 2 diabetes mellitus: A case-control study
Ala Keyany, Johannes T.H. Nielen, Patrick C. Souverein, Frank de Vries, Bart van den Bemt
Diabetes Research and Clinical Practice.2018; 139: 100.     CrossRef
Dominance of the hypothalamus-pituitary-adrenal axis over the renin-angiotensin-aldosterone system is a risk factor for decreased insulin secretion
Makoto Daimon, Aya Kamba, Hiroshi Murakami, Satoru Mizushiri, Sho Osonoi, Kota Matsuki, Eri Sato, Jutaro Tanabe, Shinobu Takayasu, Yuki Matsuhashi, Miyuki Yanagimachi, Ken Terui, Kazunori Kageyama, Itoyo Tokuda, Shizuka Kurauchi, Shigeyuki Nakaji
Scientific Reports.2017;[Epub]     CrossRef